Financials and Shareholder Letters

Financial Year 2020

Quarterly Update and Appendix 4C – Mar 2020
Appendix 4D and Half Year Accounts
Quarterly Update and Appendix 4C – Dec 2019
Quarterly Update and Appendix 4C – Sep 2019

Financial Year 2019

2019 Letter to Shareholders
Appendix 4E and Annual Report 2019
Quarterly Update and Appendix 4C – Jun 2019
Quarterly Update and Appendix 4C – Mar 2019
Appendix 4D and Half Year Accounts
Quarterly Update and Appendix 4C – Dec 2018
Appendix 4C – Quarterly Sep 2018

Financial Year 2018

2018 Letter to Shareholders
Annual Report 2018
Appendix 4E – Preliminary Final Report
Quarterly Update and Appendix 4C – Jun 2018
Quarterly Update and Appendix 4C – Mar 2018
Appendix 4D and Half Year Accounts
Appendix 4C – Quarterly Dec 2017
Appendix 4C – Quarterly Sep 2017

Financial Year 2017

2017 Letter to Shareholders
Annual Report 2017
Appendix 4E – Preliminary Final Report
Appendix 4C – Quarterly Jun 2017
Appendix 4C – Quarterly Mar 2017
Appendix 4D and Half Year Accounts
Appendix 4C – Quarterly Dec 2016
Appendix 4C – Quarterly Sep 2016

Financial Year 2016

2016 Letter to Shareholders
Annual Report 2016
Appendix 4E – Preliminary Final Report
Appendix 4C – Quarterly Jun 2016
Appendix 4C – Quarterly Mar 2016
Appendix 4D and Half Year Accounts
Appendix 4C – Quarterly Dec 2015
Appendix 4C – Quarterly Sep 2015

Financial Year 2015

Annual Report 2015

For a full list of company financial announcements visit the ASX website.

ResApp Logo White

ResApp Health Limited
ABN 51 094 468 318
Level 12, 100 Creek St, Brisbane, QLD 4000

LEGAL
Terms of Use
Privacy Policy

© 2020 ResApp Health Limited. All rights reserved. US Patent No. 10,098,569, Australian Patent No. 2013239327, Japanese Patent No. 6,435,257 and Patents Pending. ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States and other countries. ResAppDx is not available for sale in the United States.